{"name":"Incyte Biosciences Japan GK","slug":"incyte-biosciences-japan-gk","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"R-CHOP","genericName":"R-CHOP","slug":"r-chop","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"R-CHOP","genericName":"R-CHOP","slug":"r-chop","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNZF9TT2tfSGZhOFJnNlhFcnl6Y1Zka1FhMGlCYWhBalVlVldlUEFJUnE3QmRzdHNVZ3J4Z2JwaGVyZlBiQVR1dUpWNl9hcEVjSkRiM3BsVDk3LW1FTm1zdkxWcHR2RTd0SFFRbjRqZjZ6TGdMeGR0Y1d3eEUyU0p0UE02eXlRWTM0ZkpOOHdHelctWThSdnZuOQ?oc=5","date":"2026-03-02","type":"trial","source":"BioWorld News","summary":"Phase III wins lift Alumis, Corcept shares in January - BioWorld News","headline":"Phase III wins lift Alumis, Corcept shares in January","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOSTJRSi1kSTlWemVHeGY2VEluLXhhdXhFcGtHY0lrbGZibHBwRmFQYWxWX2RoVk8xc21sQXN3aUNvcG1WRE1UcnZoRW1qVHlHbC1Wemo5enZzYW5JbmlWSHl0MjBQejU1a084ckl5SUZSNjQ1eEI0SjlGdDhndWxCRUlRaFJjY0szUjdlNFhGck9aRzM1a0FBZFRCMTVTTlBKeldiYUZDY0RBMDJESC1uMXZPcUdxNU9OeVJQTFJnY2UzOXViaXc?oc=5","date":"2025-12-23","type":"regulatory","source":"BioPharma APAC","summary":"Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer - BioPharma APAC","headline":"Japan Approves Incyte’s Zynyz As First Line Treatment For Advanced Anal Canal Cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOMW43c2tQWk94aGJuNng5THBRTVRqM0FpZ0JpbWJnN2VSZ2xrV3hiVnhuY2JBWUtPUWx6dTFRYm5OcmRjZVZOczd6bDhvVk9fS3pqUHhseXFCUHdOdVZDOEF4ZHpaMF8tYjZmeUZXWG1ocHdacHdUNk55VVhhc1VvYnh3alN1Mm1PaW1oMURn?oc=5","date":"2025-12-21","type":"regulatory","source":"Yahoo Finance","summary":"Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma - Yahoo Finance","headline":"Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatme","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE0tV0NzVzV5RjFaNzRkWHFoU1lMc3Z6WmVTOE5WNEpmdE9NeFpMUl94TE5KSXVKZ1RJNjlyTHROaWJpZTBMX1czclh5N2ExRWN3bVRCM1k3MjBiSXdjMzl6d3lZaGVQcEw0?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Incyte (INCY) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $INCY - MarketBeat","headline":"Incyte (INCY) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $INCY","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE16Sm5pRWRrQTdFWjQ3bDVMbVlCRkdsOXJITHk4bl9MMXFmQ0VqalgwY05ZVkR5c0NzSW1kUEx1WGVkZ1NtLVNUYk94WHdCc09XWW15aEp0dTBhN21KcEhB?oc=5","date":"2025-04-25","type":"pipeline","source":"Nature","summary":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma - Nature","headline":"Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9IZUprMllfX3hCb3pNR1gtVWRjdGNYUk1nZHAzV0F6cTB2Q0JCYURWNHhBbWRpeElSNlpxRzNqU2I4aEdVWmhEeGVWNnpUWXNxYUc0?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"INCY Stock Price, News & Analysis - Stock Titan","headline":"INCY Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFB2cHN1NFdYT1FGUFZrQjY2dm0zeHRhczNwNUlnSXBXejFkR09HTXdveGIzekZpSkQ4MmU0SHJMWlN5eTJ2UnJiUEtfY3lRbnRXV0lTTmR6dXBRSXBMWHRhbGhXcDYtU282M3c?oc=5","date":"2024-10-27","type":"trial","source":"Wiley Online Library","summary":"Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study - Wiley Online Library","headline":"Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}